Seminars in Oncology

Aims & Scope

Seminars in Oncology brings you current, authoritative, and practical reviews of developments in the etiology, diagnosis and management of cancer.

Each issue examines topics of clinical importance, with an emphasis on providing both the basic knowledge needed to better understand a topic as well as evidence-based opinions from leaders in the field.

Seminars in Oncology also seeks to be a venue for sharing a diversity of opinions including those that might be considered "outside the box".

We welcome a healthy and respectful exchange of opinions and urge you to approach us with your insights as well as suggestions of topics that you deem worthy of coverage.

By helping the reader understand the basic biology and the therapy of cancer as they learn the nuances from experts, all in a journal that encourages the exchange of ideas we aim to help move the treatment of cancer forward.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.5
2024	3.00

SJR (SCImago Journal Rank)

Year	Value
2024	1.202

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	149

Journal Rank

Year	Value
2024	3540

Journal Citation Indicator

Year	Value
2024	375

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Role of angiogenesis in tumor growth and metastasis

  Citation: 2039

  Authors: Judah

• Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

  Citation: 749

  Authors: Roger G., Steven P., Ayad, Rafael, Philip R., Mary L., Enrica, Gerassimos A., Jesus F., Andrew R., Meletios A.

• Multiple myeloma epidemiology and survival: A unique malignancy

  Citation: 584

  Authors: Dickran

• Epidermal Growth Factor Receptor Targeting in Cancer

  Citation: 560

  Authors: J, J

• Breast Cancer Before Age 40 Years

  Citation: 542

  Authors: Carey K., Rebecca, Jennifer, Marianne, Archie

• Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implications

  Citation: 471

  Authors: Napoleone

• Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experience

  Citation: 428

  Authors: B

• Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity

  Citation: 427

  Authors: Maura L.

• The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment

  Citation: 414

  Authors: Thomas F.

• Cancer Prevention With Natural Compounds

  Citation: 368

  Authors: Norleena P., A.R.M., Soley, John M., Dong M., Fadlo R., Bharat B., Young-Joon, Omer

---